“Investors have shied away.” Edwards, a veteran antibiotics marketer, said it had become apparent that Tetraphase simply didn’t have the money to continue testing its other drugs while investing in …
More Investors Shun Startups That Target Antibiotic-Resistant Superbugs Videos